Objective: To examine healthcare providers' adherence to professional recommendations for advanced prescription of emergency contraceptive pills (ECPs).
• A substantial gap exists between the documentation of emergency contraceptive pill (ECP) advanced prescription in a training clinic and professional recommendations to integrating this service.
• Improving healthcare providers' adherence to the advanced prescription of ECP services is one step toward eliminating barriers to the immediate accessibility of ECPs.
• Each visit should be used as an opportunity to assess the risk of unintended pregnancy and ensure that emergency contraceptive counseling and advanced prescription of ECPs are addressed.
shown to increase rates of sexually transmitted infections, increase frequency of unprotected intercourse, decrease condom use, or alter the use of regular contraceptive methods. Despite professional society recommendations for ECP counseling and advanced prescription and evidence that advanced provision does not negatively affect women's reproductive health behaviors, adherence to these guidelines by clinicians has been shown to be low. [1] [2] [3] [4] Sherman et al 5 reported that only 2.4% of healthcare providers in a health maintenance organization routinely prescribed ECPs, whereas Golden et al 6 found that only 16 .7% of pediatricians routinely counseled adolescent patients about the availability of EC. In addition, UPA, which may be more effective than LNG-ECPs in preventing unintended pregnancy, requires a prescription in the United States 7 ; however, even when prescriptions are provided, immediate access to UPA in pharmacies is low. As demonstrated by Bullock et al, 8 only 2.6% of pharmacies in Hawaii made UPA immediately available, whereas 82.4% reported the immediate availability of LNG-ECPs.
Finally, the utilization of ECPs is affected not only by their accessibility but also by women's familiarity with this contraceptive method. Surveys have demonstrated that a large portion of reproductive-age women are unaware of the existence of ECPs, misunderstand their use and safety, and have insufficient knowledge to use them correctly when indicated. [9] [10] [11] [12] [13] [14] To address these obstacles, strategies of improved counseling and advanced provision or prescription of ECPs to reproductive-age women are needed, especially in geographically isolated locations for which access to EC is limited. At present, few data exist on the adherence to recommendations for advanced ECP prescription in residency training clinics. Our study sought to address these knowledge gaps and evaluated the sociodemographic factors that are associated with the provision of advanced prescription of ECPs at a teaching institution.
Methods
We conducted a retrospective chart review of all visits of nonpregnant women 14 to 25 years of age at the outpatient obstetrics and gynecology resident clinic at the Kapiolani Medical Center for Women and Children in Honolulu, Hawaii, during calendar year 2014. This office is the primary teaching clinic for the residency training program in obstetrics and gynecology at the University of Hawaii John A. Burns School of Medicine, the only civilian training program of this type in the state. Pregnant women, women who had undergone sterilization, and women seen for ancillary visits (ie, a patient is seen for a service such as a vaccination and does not meet with a physician) were excluded from the analysis. Some women had more than one eligible visit during the year, and each visit was reviewed as an independent encounter. This study was approved by the Hawaii Pacific Health Research Institute and the Western Institutional Review Board.
Demographic information collected from the electronic health record included patient age, ethnicity, race, marital status, type of insurance, and scheduled visit type. The primary contraceptive method at the end of the current visit also was recorded. For patients who concurrently used more than one contraceptive method, the method with the lowest typical use failure rate was documented. 15 Our primary outcome variable, advanced prescription of ECPs, was defined as specific chart documentation by a physician (resident or attending level) that an advanced prescription for ECPs was provided during the visit or that a patient's previously provided prescription for ECPs was still active (issued in the past 12 months). Analysis was limited to women who were clearly indicated for advanced prescription of ECPs. This included sexually active women who, at the end of their clinic visit, were not using a long-acting reversible contraception method (intrauterine device or contraceptive implant), were not actively seeking pregnancy, and did not report being in exclusively same-sex sexual relationships.
Study data were collected and managed using REDCap electronic data capture tools hosted at John A. Burns School of Medicine, University of Hawaii at Manoa. 16 Electronic data abstract forms and procedure manuals were created and reviewed for consensus by two data abstractors. Regular monitoring was conducted by the two coprincipal investigators to confirm the accuracy of data abstraction and entry.
The statistical analysis was performed using SAS version 9.4 statistical software (SAS Institute, Cary, NC). Descriptive statistics, including proportions, were computed for categorical variables. The χ 2 square and Fisher exact analyses were conducted to test the associations of age, race, scheduled visit type, contraception used at visit end, and number of visits during the calendar year with an ECP advanced prescription. These tests assumed independence of the outcome data. A logistic regression model, which accounted for nonindependent observations through generalized estimating equations, was used to identify factors associated with the provision of an ECP advanced prescription and to estimate adjusted associations (odds ratios [ORs] and 95% confidence intervals [CIs]) of age and race on this intervention. A purposeful selection algorithm was used for variable selection. 17 
Results
A total of 1039 clinical visits were reviewed. Pregnant women, women who had undergone sterilization, and ancillary visits accounted for 316 visits, which were excluded from the analysis. Among the remaining 723 visits representing 427 unique patients, 432 (59.8%) visits of 282 different patients who had indications to receive advanced prescription of ECPs during at least one visit were included in this study. Patient sociodemographic characteristics are shown in Table 1 .
The per-visit analyses demonstrated that approximately one-fifth of eligible visits (86/432, 19.9%) had documentation of an ECP advanced prescription. The per-patient analysis, which considered patients to have received an advanced prescription for ECPs if at least one of the patient's multiple visits had such documentation, demonstrated a consistent result (54/282, 19.1%). The bivariate analysis (Table 2) demonstrated that an ECP advanced prescription among adolescents aged 14 to 19 years (38.0%) was significantly more common than among young women aged 20 to 25 years (10.3%, P < 0.001). Advanced prescription of ECPs was lowest for black women (8.3%), followed by Pacific Islanders (14.6%) and Native Hawaiians (17.2%, P = 0.002). Compared with other scheduled visit types, patients scheduled for an annual examination had a significantly higher likelihood of a documented ECP advanced prescription (25.0%), followed by those scheduled for other gynecologic visits (24.6%) and postpartum visits (11.1%, P = 0.003). Patients whose contraception method at visit end was documented as the lactational amenorrhea method or the withdrawal method had the highest rate of an ECP advanced prescription (50.0%), followed by condoms (35.5%) and short-term hormonal contraceptives (including combined oral contraceptive pills, progestin-only contraceptive pills, the contraceptive patch, and the vaginal ring [31.4%, P < 0.001]). The greater number of clinic visits that a patient made during the calendar year, the more likely she was to receive an advanced prescription of ECPs. By visit ≥4, 33.3% of women received an advanced prescription of ECPs, compared with only 16% of women at their first visit (P = 0.03). In multivariable analyses adjusted for age group, race, scheduled visit type, and contraceptive method at end of visit, age group and contraception method at end of visit were independently associated with documentation of an ECP advanced prescription (Table 3) . Compared with women aged 20 to 25 years, the adjusted OR of receiving an advanced prescription for ECPs was 5.94 (95% CI 2.85-12.41) for adolescents. Compared with users of depot medroxyprogesterone acetate, the adjusted OR was 4.25 (95% CI 1.62-11.15) for condom users and 3.90 (95% CI 1.54-9.86) for users of other short-term hormonal contraceptives.
Discussion
Despite clear professional recommendations for advanced prescription of ECPs, only 20% of eligible young women seen in our obstetrics and gynecology resident clinic were found to have documentation of an ECP advanced prescription. Given that across specialties, reproductive healthcare providers have the highest percentages of reported awareness and previous prescriptions for ECPs, it is likely that in other specialty clinics even fewer patients may receive this important public health intervention. 18 Because of the practical difficulties in immediately filling ECP prescriptions, the results of this study emphasize the need for increasing healthcare provider awareness of recommendations to counsel and provide advanced prescriptions of ECPs to women of reproductive age. In addition, given the racial and ethnic disparities in unplanned pregnancy, it is concerning that women who may be the most vulnerable to unplanned pregnancy may be the least likely to receive an advanced prescription of ECPs, exacerbating this health disparity. 19 Improving healthcare providers' adherence to professional recommendations for an advanced prescription of ECPs is an important public health strategy to reduce unplanned pregnancy.
One limitation of our study is that the identification of patient race relied on documentation in the electronic health record, which may not represent the self-identified race of all of the patients. In addition, the fact that the study was conducted in a single hospital-based resident clinic may limit the generalizability of our findings. Nevertheless, the clinic has a large catchment area throughout Oahu, where 69.8% of the population of Hawaii resides, and serves as the primary outpatient training site for the only civilian obstetrics and gynecology training program in Hawaii, which points to its importance as a study population. 20 The strengths of this study are that we analyzed the entire population of clinic visits by nonpregnant women 14 to 25 years old during a calendar year. The evaluation during a calendar year provides the most accurate reflection of standard practice in this clinical setting because it accounts for seasonal variations in patient behaviors and the cycle of resident and attending physicians in the clinic. In addition, to optimize the accuracy of documentation of an ECP advanced prescription, we reviewed all of the available aspects of the medical records, including resident and attending-level physician notes and prescription histories, and did not rely on lower-fidelity methods such as charge codes.
Conclusions
A substantial gap exists between the documentation of an ECP advanced prescription and professional recommendations to integrate such services into all clinical visits. Improving healthcare providers' adherence to advanced prescription of ECPs is one step toward reducing barriers to the immediate accessibility of ECPs, which in turn can contribute to a reduction in unintended pregnancies.
